Testing effectiveness (Phase 2)Ended earlyNCT00274651
What this trial is testing
A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas
Who this might be right for
Cutaneous T-Cell LymphomaPeripheral T-Cell LymphomaNon-Hodgkin's Lymphoma
Valerio Therapeutics 53